Rapid infectious disease test CryptoPS
for antigensCryptococcus neoformansserum

rapid infectious disease test
rapid infectious disease test
Add to favorites
Compare this product


for infectious diseases
Tested parameter
for antigens
Cryptococcus neoformans
Sample type
serum, plasma, whole blood
Analysis mode


For the semi-quantitative detection of Cryptococcus sp. antigens in whole blood, serum, plasma and CSF Quick - Easy manipulation in only 2 steps - Semi-quantitative result within 10 minutes - Titration procedure available Clinical studies - Evaluated by the NRC for Invasive Mycoses and Antifungals (Pasteur Institute, Paris) * - Evaluated by the Department of Clinical Microbiology and Infectious Diseases at the University of the Witwatersrand (Johannesburg), Sriruttan C et al., ECCMID, 2016 Traceability - Compatibility with Biosynex® Reader for results recording - Positive and negative controls included THE SOLUTION Cryptotoccosis is an opportunistic and cosmopolitan disease caused by Cryptococcus neoformans. Infection occurs most often in childhood and by inhalation of spores. Cryptococcosis is the second leading cause of death in immunocompromised patients (HIV, transplants). The most common clinical expression of the disease is meningoencephalitis. There are approximately 1 million new cases each year worldwide including 625,000 deaths from cryptococcal meningitis (source: CDC). The vast majority of cases occur in Sub-Saharan Africa (> 70%), followed by Asia. BIOSYNEX® CryptoPS is a rapid immunochromatographic test for the semi-quantitative detection and titration of Cryptococcus sp. capsular antigens in serum, plasma, whole blood and CFS to guide the diagnosis of cryptococcal infections, especially in cases of meningitis.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.